JPRN-UMIN000016196尚未招募2 期
A phase II study of low dose nab-paclitaxel as second-line chemotherapy for unresectable or recurrent gastric cancer - A phase II study of nab-paclitaxel as second-line chemotherapy for gastric cancer
Department of Digestive Surgery and Surgical Oncology, Yamaguchi University Graduate School of Medicine0 个研究点目标入组 37 人开始时间: 2015年1月13日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 37
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients with serious drug allergy 2. Patients with history of receiving paclitaxel treatment 3. Patients with infectious disease and febrile condition (over 38 centigrade) 4. Patiens with any other serious disease. 5. Patients with severe diarrhea 6. Patients with fresh bleeding from intestinal tract. 7. Patients with serious heart disease 8. Presence of active multiple primaries. (Active multiple primaries is simultaneous or metachronous with disease-free interval of 5 years or more. But, carcinoma in situ and skin cancer which are judged to be recovery by medical treatment are excluded.) 9. Patients with peripheral neuropathy(=>Grade2) 10. Patients wit psychological illness 11. Pregnant or nursing female 12. Patient with brain metastasis. 13. Not appropriate for the study at the physician's assessment
研究者
相似试验
已完成
2 期
Phase II study of low-dose Nab-paclitaxel for advanced breast cancerBreast CancerJPRN-UMIN000012048Kitasato University Kitasato Institute Hospital20
招募中
2 期
Phase 2 study of dose-dense nab-paclitaxel followed by EC as neoadjuvant chemotherapy for HER2-negative breast cancerHER2-negative primary breast cancerJPRN-UMIN000026143Teikyo University School of Medicine50
已完成
不适用
A phase II study of nab-paclitaxel for pretreated non-small cell lung canceron-small cell lung cancerJPRN-UMIN000012972Kanagawa Cancer Center30
已完成
2 期
Randomized phase II study of nab-Paclitaxel (nab-PTX) plus Carboplatin(CBDCA) followed by maintenance nab-PTX or TS-1 plus CBDCA followed by maintenance TS-1 as first-line treatment in patients with stage IIIB/IV squamous cell carcinoma of the lung.squamous cell carcinoma of the lungJPRN-UMIN000012903Internationanl University of Health and Welfare, Respiratory Disease center58
招募中
2 期
A Phase II trial of nab-paclitaxel followed by EC as neoadjuvant chemotherapy for resectable breast cancer.breast cancerJPRN-UMIN000017382Tokyo Women's Medical University,Department of endocrine surgery36